General Historical Use Modern Use Spiritual & Ritual Use Health Neuroprotection Ethnobotany Pharmacology & Chemisty Pregnancy

Search Periodicals :

GENERAL

Cannabinoids and Appetite Stimulation, by R.D. Mattes; K. Engelman; L.M. Shaw; M.A. Elsohly

Pharmacology, Biochemistry and Behavior, Vol. 49, 1994; 187-195
[Excerpts]

Cannabis 1988: Old Drug, New Dangers, The Potency Debate, by T.H. Mikuriya; M.R. Micheal

Journal of Psychoactive Drugs, Vol. 20 (No 1) Jan-Mar 1988; 47
[Excerpts]

Constituents of Cannabis sativa L.XXIV: The Potency of Confiscated Marijuana, Hashish, and Hash Oil Over a Ten-Year Period, by M.A. Elsohly; J.H. Holley; G.S. Lewis; M.H. Russell; C.E. Turner

Journal of Forensic Sciences, Vol. 29 (No 2) April 1984; 500-514

Marihuana and Scopolamine "High", by H. Graff, MD

American Journal of Psychiatry, Vol 125, Mar 9, 1969, 1258-1259
[Full Text] [Hardcopy]

Degradation & Mold: A Collection of Articles Regarding Aging of Cannabis, by Erowid

[ View References ]

HISTORICAL

Marijuana in Ancient Greece and Rome? The Literary Evidence, by T.F. Brunner, PhD

Journal of Psychedelic Drugs, Vol 9 (No. 3) Jul-Sep 1977, 221-225
[Hardcopy]

Charas. The Resin of Indian Hemp, by T.B. Wood; W.T.N. Spivey; T.H. Easterfield

Journal Chem Soc., Vol 69; 1896, 539-546

Cannabis Indica Resin. Part II, by R.S. Cahn

Journal Chem Soc., 1931, 630

A Critical Survey of the Literature Dealing with the Chemical Constituents of Cannabis sativa, by A.H. Blatt

Journal of Washington Academy of Sciences, Vol 28 (No 11) 1940, 465-477

MODERN USE

Runaways, Hippies, and Marihuana, by J. Kaufman; J.R. Allen, MD; L.J. West, MD

American Journal of Psychiatry, Vol 126, Nov 5, 1969, 717-720
[Full Text] [Hardcopy]

The Marihuana Problem: An Overview, by William H. McGlothlin, PhD; Louis Jolyon West, MD

American Journal of Psychiatry, Vol 125, Sept 3, 1968, 370-378
[Hardcopy]

Marihuana -- Thirty-five Years Later, by Walter Bromberg, MD

American Journal of Psychiatry, Vol 125, Sept 3, 1968, 391-393
[Full Text] [Hardcopy]

SPIRITUAL USE

Tantric cannabis use in India, by M.R. Aldrich

Journal of Psychedelic Drugs, Vol 9 (No. 3) Jul-Sep 1977; 227-233
[Abstract]

HEALTH

Acute renal infarction and heavy marijuana smoking.

Nephron., Vol 70, Nov 4, 1995, 494-6
[Abstract]

Adverse Reaction to Marihuana, by M.H. Keeler, MD

American Journal of Psychiatry, Vol 124, Nov 5, 1968, 678-679
[Hardcopy]

Adverse effects of cannabis, by Hall W, Solowij N

The Lancet,1998 Nov 14;352(9140):1611-6
[Full Text]

Comparative Epidemiology of Dependence on Tobacco, Alcohol, Controlled Substances, and Inhalants: Basic Findings from the National Comorbidity Survey, by Anthony JC, Warner LA, Kessler RC

Experimental and Clinical Psychopharmacology,1994 2:244-68
[Abstract]

Cannabis Use and Cognitive Decline in Persons Under 65 Years of Age, by C.G. Lyketsos; E. Garrett; K. Liang; J.C. Anthony

American Journal of Epidemiology, Vol 149 (No. 9) 1999, 794-800
[Full Text]

Marijuana use and mortality, by Sidney S, Beck JE, Tekawa IS, Quesenberry CP, Friedman GD

American Journal of Public Health, 1997 Apr;87(4):585-90
[Full Text]

Effects of Chronic Marijuana Use on Human Cognition, by R.I. Block; M.M. Ghoneim

Psychopharmacology, Vol 110; 1993, 219-228

Effects of Smoked Marijuana on Heart Rate, Drug Ratings and Task Performance by Humans, by T.H. Kelly; R.W. Foltin; M.W. Fischman

Behavioural Pharmacology, Vol 4; 1993, 167-17

Heavy Marijuana Use and Recent Memory Impairment, by R.H. Schwartz

Psychiatric Annals, 1991, 80-82

Marijuana as Anti-emetic Medicine: A Survey of Oncologists' Experiences and Attitudes, by R. Doblin; M. Kleiman

Journal of Oncology, 1991
[Abstract]

Residual effects of chronic cannabis treatment on behavior in mature rats, by A. Stiglick; H. Kalant

Psychopharmacology, Vol 85 (No. 4) Apr 1985, 436-439
[Abstract]

Effects of varying marijuana potency on deposition of tar and delta9-THC in the lung during smoking, by P. Matthias; D.P. Tashkin; J.A. Marques-Magallanes; J.N. Wilkins; M.S. Simmons

Pharmacol Biochem Behav, Vol 58 (No. 4) Dec 1997; 1145-1150
[Abstract]

Non-acute (residual) neurocognitive effects of cannabis use: A meta-analysis study, by Grant I, Gonzalez R, Cary C, Natarajan L, Wolfson T

J Int Neuropsychological Society, 9:679-680 2003
[View Article]

NEUROPROTECTION

Cannabis Science: Cannabinoid Derivative Protects Neurons, by R.H.B. Fishman

The Lancet, Vol 348 (No 9039) Nov 23, 1996
[Full Text]

Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures, by Shen M, Piser TM, Seybold VS, Thayer SA

J Neurosci, 16(14):4322-34 1996
[View Article]

Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid, by Gallily R, Yamin A, Waksmann Y, Ovadia H, Weidenfeld J, Bar-Joseph A, Biegon A, Mechoulam R, Shohami E

J Pharmacol Exp Ther, 283(2):918-24 1997
[View Article]

Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity, by Shen M, Thayer SA

Mol Pharmacol, 54(3):459-62 1998
[View Article]

Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures, by Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA

J Neurosci, 19(8):2987-95 1999
[View Article]

Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity, by van der Stelt M, Veldhuis WB, Bar PR, Veldink GA, Vliegenthart JF, Nicolay K

J Neurosci, 21(17):6475-9 2001
[View Article]

Cannabinoids and brain injury: therapeutic implications, by Mechoulam R, Panikashvili D, Shohami E

Trends Mol Med, 8(2):58-61 2002
[View Article]

Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases, by Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JF, Bar PR, Nicolay K, Di Marzo V

J Neurosci, 23(10):4127-33 2003
[View Article]

CB1 cannabinoid receptors and on-demand defense against excitotoxicity, by Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, Lopez-Rodriguez ML, Casanova E, Schatz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B

Science, 302(5642):84-8 2003
[View Article]